Find uplifting stories about heroes, innovations, and solutions
14 results for "lyme disease"
The federal government just announced one of the most ambitious campaigns ever to fight Lyme disease, which affects nearly half a million Americans every year. New tick control programs, AI-powered diagnostics, and $2.5 million in innovation prizes aim to turn the tide on this growing health threat.
A simple trail trick could make walks in the woods safer for everyone. University of Ottawa researchers discovered that spreading woodchips on forest paths cuts tick populations dramatically.
After decades without a vaccine option, Pfizer's new Lyme disease vaccine showed over 70% effectiveness in preventing infection among 9,400 participants. The breakthrough could protect the 476,000 Americans infected annually from a disease that often leads to chronic arthritis and heart problems.
For the first time in decades, a vaccine to prevent Lyme disease is showing real promise. Pfizer's new vaccine candidate demonstrated over 75% effectiveness in a major clinical trial, offering hope to millions who spend time outdoors.
A promising new Lyme disease vaccine from Pfizer and Valneva could protect against nearly half a million annual U.S. infections. The shot targets bacteria inside ticks before they can infect people.
A University of Kentucky scientist is turning Lyme disease bacteria against itself in a promising new treatment approach. The breakthrough comes as tick-borne illnesses have jumped 128% nationwide since 2020.
After more than 20 years without a Lyme disease vaccine in the U.S., Pfizer's new four-dose vaccine shows promising results that could protect millions from the most common tick-borne illness in America. The vaccine, tested across thousands of people in the U.S., Canada, and Europe, marks a hopeful step forward for outdoor enthusiasts and those living in high-risk areas.
Pfizer and Valneva's experimental Lyme disease vaccine proved highly effective in Phase III trials, bringing hope to millions who love the outdoors. If approved, it would be the first Lyme vaccine available in two decades.
After decades without a Lyme vaccine, Pfizer's new candidate proved more than 70% effective at preventing the disease in a major clinical trial. The breakthrough brings hope to millions who face the threat of this debilitating illness every time they step outdoors.
A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness. After decades without protection, regulatory approval could arrive soon for people ages five and up.
A new vaccine could soon protect people from Lyme disease for the first time in over 20 years. Pfizer and Valneva's candidate showed over 70% effectiveness in preventing the tick-borne illness that affects hundreds of thousands annually.
A new Lyme disease vaccine from Pfizer has shown 70% effectiveness in clinical trials, offering hope for protection against the tick-borne illness that affects hundreds of thousands annually. This marks the first promising Lyme vaccine in over two decades.
A pharmaceutical company has achieved a 100% cure rate for a dangerous tick-borne disease in patients whose immune systems couldn't fight it off. The breakthrough could reshape treatment guidelines for babesiosis, a debilitating illness that often strikes alongside Lyme disease.
Two determined moms and Yale researchers solved a medical mystery that was crippling children across Connecticut. Their discovery led to treatments that now help nearly half a million Americans recover each year.